Exclusivity Patents and exclusivity Drug Information Prescribing and other information DMFs Type 2 master files Databases Free access to database search 21 CFR FDA regulations for this API Federal Register FR search results for this API Drug Recalls For Rx's using this API

FDA Approval Activities for this Drug… NIMOTOP (nimodipine) Capsules,30 mg, Bayer Pharmaceutical Division NDA 18-869/S10 8/22/00 8/23/00 8/23/00 NIMOTOP (nimodipine) Capsules,Rx Bayer Pharmaceutical Division NDA 18-869 8/22/00 Nimotop Indications: for the improvement of neurological outcome by reducing the incidence and severity of ischemic deficits in patients with subarachnoid hemorrhage from ruptured intracranialberry aneurysms regardless of their post-ictus neurologic condition. | Nimotop (Nimodipine) capsules, Bayer Pharma, Labeling Revision Check the most up-to-date list of FDA Approvals.   A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | News Feed for each API | DMF Index | Pharma Job Search | FindingHealthOnline © 2008 Betterchem Corp.